Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4537398016 | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4537399012 | Pyrimidine analogue antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4537400017 | Pyrimidine analog antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4537401000052113 | läkemedel som innehåller pyrimidinanalog | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Is a | Product containing antimetabolite (product) | true | Inferred relationship | Some | ||
| Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Has active ingredient | Pyrimidine analog (substance) | true | Inferred relationship | Some | 1 | |
| Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Is a | Nitrogen and/or nitrogen compound-containing product | true | Inferred relationship | Some | ||
| Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing capecitabine (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing gemcitabine (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing fluorouracil (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing floxuridine (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing cytarabine (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing tegafur and uracil (medicinal product) | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| fluorouracil 1 %, lösning | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing azacitidine (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing decitabine (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing tegafur (medicinal product) | Is a | True | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing uracil (medicinal product) | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing fluorouracil (18-F) (medicinal product) | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| liposomalt cytarabin | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| fluorouracil (som fluorouracilnatrium) 2,5 g/100 ml, injektionsvätska, lösning, flaska | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| fluorouracil (som fluorouracilnatrium) 250 mg/10 ml, injektionsvätska, lösning, flaska | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| fluorouracil (som fluorouracilnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| fluorouracil (som fluorouracilnatrium) 500 mg/10 ml, injektionsvätska, lösning, flaska | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| fluorouracil (som fluorouracilnatrium) 2,5 g/50 ml, infusionsvätska, lösning, flaska | Is a | False | Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR